Tempest TherapeuticsTPST
13F holders, Q2 2026 (June 30)20holders −1
4new positions
5sold out
1famous investor
$1.11avg. 13F price*
At the end of Q2 2026, 20 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, down 1 from Q1 2026. 4 opened new positions and 5 sold out. The largest holders were Sabby Management, LLC ($568K), Vanguard Capital Management LLC ($260K) and Geode Capital Management, LLC ($96K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $57K |
| Exits | 5 | $74K |
All 13F filers, Q1 2026 → Q2 2026: 552,694 shares bought and 45,267 shares sold, net +507,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Sabby Management, LLC | 4.79% | Add +2763.4% | 511,286 | $568K |
| Vanguard Capital Management LLC | 0.00% | No change | 233,888 | $260K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.4% | 86,625 | $96K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 68,908 | $76K |
| BlackRock, Inc. | 0.00% | No change | 39,068 | $43K |
| Squarepoint Ops LLC | 0.00% | New | 30,900 | $34K |
| Northern Trust Corp. | 0.00% | Add +43.3% | 20,136 | $22K |
| Citadel Advisors | 0.00% | New | 19,820 | $22K |
| UBS Group AG | 0.00% | Add +24.3% | 5,636 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.6% | 3,922 | $4K |
| Morgan Stanley | 0.00% | Reduce -1.8% | 2,022 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -1.1% | 1,513 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 292 | $324 |
| Jones Financial Companies LLLP | 0.00% | No change | 239 | $258 |
| Barclays PLC | 0.00% | New | 222 | $246 |
| SBI Securities Co., Ltd. | 0.00% | No change | 56 | $62 |
| Parallel Advisors, LLC | 0.00% | No change | 18 | $20 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $3 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 3 | $3 |
| Royal Bank of Canada | 0.00% | Add +3.7% | 28 | $0 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.